Real-world Observations Show Beneficial Outcomes in Patients with NSCLC Treated with Pembrolizumab for More than 2 Years
07:30am - 03:45pm EDT - April 1, 2023
07:30am - 03:45pm EDT - April 1, 2023
Author(s):
- Dr Anupama Vasudevan, BDS, MPH, PhD, Senior Director of HEOR Analytics, PQ, Integra Connect LLC
Tags: Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| Final_Pembrolizumab DOT and TTNT_031523 _1_.pdf | Download Handout |